VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
BNTC
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
BNTCBenitec Biopharma Inc.
$12.70$333M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksBNTCQuarterly Financials

Benitec Biopharma Inc. (BNTC) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Benitec Biopharma Inc. (BNTC) quarterly income statement — complete revenue, gross profit & net income history

BNTC Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ3'26Q2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21
Sales/Revenue000000000007K54K14K0048K25K02K
Revenue Growth %--------100%-100%-100%--12.5%-44%--100%4700%2400%-100%105%
Cost of Goods Sold00000000-3K1K-106K00009K0001K
COGS % of Revenue-------------------50%
Gross Profit000000003K-1K106K7K54K14K0-9K48K25K01K
Gross Margin %-----------100%100%100%--100%100%-50%
Gross Profit Growth %-----100%100%-100%-100%-94.44%-107.14%-177.78%12.5%-44%--1000%900%25%100%101.14%
Operating Expenses13.58M13.38M9.8M17.18M15.34M10.8M5.79M5.55M4.14M6.93M5.98M4.56M4.39M5.62M4.58M4.73M3.51M4.86M4.82M3.86M
OpEx % of Revenue-----------65100%8138.89%40171.43%--7308.33%19440%-192800%
Selling, General & Admin7.28M7.54M6.43M13.48M8.84M5.42M2.21M2.04M1.58M1.82M1.55M1.37M1.23M1.86M1.92M1.55M1.34M1.71M2.04M1.54M
SG&A % of Revenue-----------19585.71%2274.07%13307.14%--2785.42%6856%-76800%
Research & Development6.3M5.83M3.37M3.69M6.5M5.38M3.58M3.51M2.57M5.1M4.43M3.19M3.17M3.76M2.66M3.18M2.17M3.15M2.78M2.32M
R&D % of Revenue-----------45514.29%5864.81%26864.29%--4522.92%12584%-116000%
Other Operating Expenses00000000000000000000
Operating Income-13.58M-13.38M-9.8M-17.18M-15.34M-10.8M-5.79M-5.55M-4.14M-6.93M-5.87M-4.55M-4.34M-5.61M-4.58M-4.74M-3.46M-4.83M-4.82M-3.85M
Operating Margin %------------65000%-8038.89%-40071.43%---7208.33%-19340%--192750%
Operating Income Growth %11.43%-23.8%-69.28%-209.59%-270.32%-55.98%1.41%-21.93%4.61%-23.48%-28.25%3.97%-25.46%-16.03%5.02%-22.91%8.78%-48.36%-79.26%-33.53%
EBITDA-13.46M-13.26M-9.69M-17.06M-15.23M-10.72M-5.7M-5.46M-4.05M-6.85M-5.79M-4.47M-4.25M-5.51M-4.48M-4.67M-3.35M-4.72M-4.72M-3.75M
EBITDA Margin %------------63800%-7866.67%-39342.86%---6970.83%-18888%--187650%
EBITDA Growth %11.6%-23.62%-69.91%-212.59%-275.93%-56.62%1.59%-22.19%4.64%-24.31%-29.34%4.47%-26.96%-16.65%5.13%-24.57%9.03%-50.19%-81.68%-33.99%
D&A (Non-Cash Add-back)119K120K118K118K106K81K91K91K90K80K82K84K93K102K102K63K114K113K102K102K
EBIT-13.58M-13.38M-9.8M-17.18M-15.34M-10.8M-5.79M-5.47M-4.14M-6.79M-5.87M-4.65M-4.39M-5.4M-5.08M-5.06M-3.27M-4.81M-5.04M-3.85M
Net Interest Income1.59M000823K823K00-4K-6K-6K-8K-7K-9K-9K-10K-10K-11K-1K-1K
Interest Income1.59M000823K823K00000000000000
Interest Expense000000004K6K6K8K7K9K9K10K10K11K1K1K
Other Income/Expense1.65M1.54M838K1.03M834K1.25M732K828K-138K129K-80K-111K-56K199K-513K-329K185K14K-223K-148K
Pretax Income-11.94M-11.84M-8.96M-16.15M-14.5M-9.55M-5.06M-4.72M-4.28M-6.8M-5.95M-4.66M-4.4M-5.41M-5.09M-5.07M-3.27M-4.82M-5.04M-4M
Pretax Margin %------------66585.71%-8142.59%-38650%---6822.92%-19284%--200150%
Income Tax00000000000000000000
Effective Tax Rate %0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%
Net Income-11.94M-11.84M-8.96M-16.15M-14.5M-9.55M-5.06M-4.72M-4.28M-6.8M-5.95M-4.66M-4.4M-5.41M-5.09M-5.07M-3.27M-4.82M-5.04M-4M
Net Margin %------------66585.71%-8142.59%-38650%---6822.92%-19284%--200150%
Net Income Growth %17.7%-23.92%-77.21%-242.1%-238.89%-40.51%15.03%-1.27%2.68%-25.63%-16.91%8.01%-34.26%-12.24%-0.95%-26.58%16.22%-48.25%-85.61%-36.39%
Net Income (Continuing)-11.94M-11.84M-8.96M-16.15M-14.5M-9.55M-5.06M-4.72M-4.28M-6.8M-5.95M-4.66M-4.4M-5.41M-5.09M-5.07M-3.27M-4.82M-5.04M-4M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)-0.24-0.26-0.22-0.39-0.24-0.33-0.48-0.53-0.23-1.32-1.38-1.42-2.67-1.61-4.39-5.27-3.22-5.02-5.25-4.82
EPS Growth %0%21.21%54.17%26.42%-4.35%75%65.22%62.54%91.39%17.76%68.56%73.15%16.95%68%16.38%-9.34%54.07%22.01%74.81%78.77%
EPS (Basic)-0.24-0.26-0.22-0.39-0.24-0.33-0.48-0.53-0.23-1.32-1.38-1.42-2.67-1.61-4.39-5.27-3.22-5.02-5.25-4.82
Diluted Shares Outstanding49.39M45.97M41.52M36.21M38.6M22.08M10.64M10.09M10.47M10.31M8.63M6.58M1.65M6.49M2.55M1.92M1.92M1.92M1.92M1.66M
Basic Shares Outstanding49.39M45.97M41.52M36.21M38.6M22.08M10.64M10.09M10.44M10.3M8.63M6.58M1.65M6.48M2.55M1.92M1.92M1.92M1.92M1.66M
Dividend Payout Ratio--------------------